Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...

The Government of India has formally launched the news Guidelines of the MGNAREGA based on the Mihir Shah Committee report. The news guidelines include many new works under conservation activities and it strengthens the hands of the village panchayats and gram sabhas. However, the list of works does not include the activities under the system of rice intensification (SRI) which encourages scientific method of paddy cultivation with better yield in...

The Medical Council of India (MCI) has decided to take stern action against doctors who had endorsed scientific recommendations submitted to the Central Drugs Standard Control Organization (CDSCO), which were written by drug companies themselves. TOI reported on Thursday how drug companies have been caught red-handed writing scientific recommendations of their own drugs and submitting them to the Drug Controller General of India (DCGI) after getting them endorsed by reputed doctors...

-PTI Study claims more than half of them died in the first 28 days of their life More than 16.8 lakh children under five years died of infectious, but preventable, diseases in India in 2010 and more than half of them could not complete the first month of their life, a new study has claimed. Of the total deaths, 52 per cent, or about 0.875 million, were among the children who died in...

A key finding in the report was that several multinational firms had launched drugs without conducting mandatory clinical trials or seeking expert medical opinion The health ministry has denied the presence of any systemic rot in the drug approval process and pharmaceutical firms have refuted charges of collusion after a report by a parliamentary panel pointed to regulatory lapses in clinical trials. The panel, which looked into the functioning of Central Drugs...